Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase
Sponsor: III. Medizinische Klinik Mannheim
A PHASE3 clinical study on Leukemia, this trial is ongoing. The trial is conducted by III. Medizinische Klinik Mannheim and has accumulated 6 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jul 1997
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- III. Medizinische Klinik Mannheim
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Aalen, Germany , Aarau, Switzerland , Amberg, Germany , Ansbach, Germany , Aschaffenburg, Germany , Augsburg, Germany , Baar, Switzerland , Bad Hersfeld, Germany , Basel, Switzerland and 113 more locations